Literature DB >> 15232303

Cathepsin B and L are involved in degradation of prions in GT1-1 neuronal cells.

Katarina M Luhr1, Elin K Nordström, Peter Löw, Krister Kristensson.   

Abstract

In scrapie-infected cells, the abnormal isoform of the prion protein, PrP(Sc), accumulates in endosomes/lysosomes. In this study, the involvement of two lysosomal proteases, cathepsin B and L, in cellular processing of PrP(Sc) was analyzed in immortalized neuronal gonadotropin-releasing hormone cells (GT1-1) infected with scrapie. Treatment with inhibitors of either cathepsin B or L resulted in accumulation of PrP(Sc). Such an increased accumulation also occurred when the activities of both cathepsins were inhibited using RNA interference. We conclude that cathepsin B and L are involved in the degradation of PrP(Sc) in scrapie-infected GT1-1 cells and that they can compensate for each other's functions. This study shows that specific proteases, abundantly present in neurons, have the capacity to degrade PrP(Sc).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15232303     DOI: 10.1097/01.wnr.0000134931.81690.34

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  15 in total

1.  Membranous complexes characteristic of melanocytes derived from patients with Hermansky-Pudlak syndrome type 1 are macroautophagosomal entities of the lysosomal compartment.

Authors:  Justin W Smith; Amy Koshoffer; Randal E Morris; Raymond E Boissy
Journal:  Pigment Cell Res       Date:  2005-12

2.  A specific population of abnormal prion protein aggregates is preferentially taken up by cells and disaggregated in a strain-dependent manner.

Authors:  Young Pyo Choi; Suzette A Priola
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

3.  Cysteine cathepsins are essential in lysosomal degradation of α-synuclein.

Authors:  Ryan P McGlinchey; Jennifer C Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

4.  Cellular prion protein regulates its own α-cleavage through ADAM8 in skeletal muscle.

Authors:  Jingjing Liang; Wei Wang; Debra Sorensen; Sarah Medina; Sergei Ilchenko; Janna Kiselar; Witold K Surewicz; Stephanie A Booth; Qingzhong Kong
Journal:  J Biol Chem       Date:  2012-03-23       Impact factor: 5.157

5.  Correlation of cellular factors and differential scrapie prion permissiveness in ovine microglia.

Authors:  Kelcey D Dinkel; David A Schneider; Juan F Muñoz-Gutiérrez; Valerie R McElliott; James B Stanton
Journal:  Virus Res       Date:  2017-07-25       Impact factor: 3.303

6.  Endogenous proteolytic cleavage of disease-associated prion protein to produce C2 fragments is strongly cell- and tissue-dependent.

Authors:  Michel Dron; Mohammed Moudjou; Jérôme Chapuis; Muhammad Khalid Farooq Salamat; Julie Bernard; Sabrina Cronier; Christelle Langevin; Hubert Laude
Journal:  J Biol Chem       Date:  2010-02-12       Impact factor: 5.157

7.  Cardiac glycoside-mediated turnover of Na, K-ATPases as a rational approach to reducing cell surface levels of the cellular prion protein.

Authors:  Mohadeseh Mehrabian; Xinzhu Wang; Shehab Eid; Bei Qi Yan; Mark Grinberg; Murdock Siegner; Christopher Sackmann; Muhammad Sulman; Wenda Zhao; Declan Williams; Gerold Schmitt-Ulms
Journal:  PLoS One       Date:  2022-07-01       Impact factor: 3.752

8.  Anaplasma phagocytophilum increases cathepsin L activity, thereby globally influencing neutrophil function.

Authors:  Venetta Thomas; Swapna Samanta; Erol Fikrig
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

9.  NMDA Receptor and L-Type Calcium Channel Modulate Prion Formation.

Authors:  Marco Zattoni; Chiara Garrovo; Elena Xerxa; Giada Spigolon; Gilberto Fisone; Krister Kristensson; Giuseppe Legname
Journal:  Cell Mol Neurobiol       Date:  2020-04-01       Impact factor: 5.046

10.  Inhibition of cholesterol recycling impairs cellular PrP(Sc) propagation.

Authors:  Sabine Gilch; Christian Bach; Gloria Lutzny; Ina Vorberg; Hermann M Schätzl
Journal:  Cell Mol Life Sci       Date:  2009-10-13       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.